Qiao Zhou
88 Jiefang Road
Hangzhou, China
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Generation of hypoimmunogenic gastric insulin-secreting organoids.
Journal: bioRxiv : the preprint server for biology
Published: July 29, 2026
The Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide Attenuates Colon Cancer Development by Regulating Glucose Metabolism.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 27, 2024
DOT1L protects against podocyte injury in diabetic kidney disease through phospholipase C-like 1.
Journal: Cell communication and signaling : CCS
Published: August 10, 2024
Rapid Correction of the Hypoglycemia State in Nonhuman Primates Using a Glucagon Long-Dissolving Microneedle Patch.
Journal: ACS biomaterials science & engineering
Published: April 08, 2024
Novel Angiogenesis Role of GLP-1(32-36) to Rescue Diabetic Ischemic Lower Limbs via GLP-1R-Dependent Glycolysis in Mice.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: March 21, 2024
Associations between cardiometabolic indices and the risk of diabetic kidney disease in patients with type 2 diabetes.
Journal: Cardiovascular diabetology
Published: February 27, 2024
ELABELA/APJ Axis Prevents Diabetic Glomerular Endothelial Injury by Regulating AMPK/NLRP3 Pathway.
Journal: Inflammation
Published: May 04, 2023
Sappanone a prevents diabetic kidney disease by inhibiting kidney inflammation and fibrosis via the NF-κB signaling pathway.
Journal: Frontiers in pharmacology
Published: May 25, 2022
Liraglutide prevents high glucose induced HUVECs dysfunction via inhibition of PINK1/Parkin-dependent mitophagy.
Journal: Molecular and cellular endocrinology
Published: October 07, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026